4/28/17: The “Who, When & Why” of Testosterone Replacement Therapy
Video taken from the channel: UW Department of Medicine
A New Deep Dive on Peptides with Expert, Ryan Smith
Video taken from the channel: Ben Pakulski Muscle Intelligence
NEW WAY OF TAKING TESTOSTERONE???
Video taken from the channel: uppercaseCHASE1
AIDS-Related Opportunistic Infections Beata Casanas, DO
Video taken from the channel: IDPodcasts
Scientists say newly developed nasal spray can help fight COVID-19
Video taken from the channel: WKYC Channel 3
NASAL TESTOSTERONE PRESERVES FERTILITY
Video taken from the channel: Ivanhoe Web
Nasal testosterone preserves fertility
Video taken from the channel: KSAT 12
July 23, 2019 Jeremy Gray. New Testosterone Nasal Spray Receives U.S. Patent. The University of Texas at Austin’s College of Liberal Arts received their second patent ever from psychology professor Bob Josephs’ testosterone nasal spray. This testosterone-containing nasal spray has been designed to help men and women who suffer from depression, anxiety, and sexual.
Search the College of Liberal Arts. Department of Psychology; About the Department About and Mission. EP2709588A1 EP12738595.3A EP12738595A EP2709588A1 EP 2709588 A1 EP2709588 A1 EP 2709588A1 EP 12738595 A EP12738595 A EP 12738595A EP 2709588 A1 EP2709588 A1 EP 2709588A1 Authority EP European Patent Office Prior art keywords testosterone gel intranasal testosterone gel anyone Prior art date 2011-05-15 Legal status (The legal status is an.
The new patent issued by the US Patent Office to ARS on June 16, 2020 (U.S. Patent No. 10,682,414), also with expiration in 2038, covers methods related to the use and intranasal administration for a dose range of 0.1 to 2.4 mg epinephrine for the treatment of a type 1 hypersensitivity allergic reaction with any nasal formulation.
“Testosterone is not sedating.” The nasal spray (United States Patent No. 10,258,63, issued on April 16, 2019) has been licensed to Acerus Pharmaceuticals Corporation, which has the flexibility under the current agreement to use the technology in whatever medical field it deems most appropriate. The patent, titled “ Treatment of Demyelinating Diseases ” (U.S. Appl.
No. 16/506,830), is valid until 2039, and covers the use of a steroid hormone, such as testosterone, in combination with a. Singh continued, “Once issued, this patent will be a key component of our commercial protection strategy for PH10 in the U.S., in a manner similar to our issued U.S. patent for therapeutic uses.
AUSTIN, Texas — A newly patented, testosterone-containing nasal spray developed by a psychology professor at The University of Texas at Austin could provide those suffering from testosterone deficiency and other ailments, such as anxiety disorders, with easily modulated, fast-acting results. There is a new option for treating testosterone deficiency in adult men. I know, there are already gels, patches, injections and adhesive patches you stick on your gums but apparently, we need one more and… wait for it… it’s a nasal gel.Natesto is the first nasal testosterone gel approved in the United States for the treatment of male hypogonadism and testosterone. VistaGen Therapeutics Receives Notice of Allowance for U.S.
Patent for Treatment of Depression with PH10 VistaGen’s investigational new generation CNS nasal spray in Phase 2 development for.
List of related literature:
|from Urogynecology and Reconstructive Pelvic Surgery E-Book|
|from Lehne’s Pharmacology for Nursing Care E-Book|
|from Williams Textbook of Endocrinology E-Book|
|from The Natural Superwoman: The Scientifically Backed Program for Feeling Great, Looking Younger, and Enjoying Amazing Energy at Any Age|
|from Medical-Surgical Nursing E-Book: Assessment and Management of Clinical Problems, Single Volume|
|from Skin Permeation and Disposition of Therapeutic and Cosmeceutical Compounds|
|from Comprehensive Care of the Transgender Patient E-Book|
|from Management of Common Problems in Obstetrics and Gynecology|
|from Everything Below the Waist: Why Health Care Needs a Feminist Revolution|